Historical record - last NADAC publication: 1/10/2018

Product Information

HYDROMORPHONE HCL ER 32 MG TAB is a generic product labeled by Padagis US LLC, priced at $40.1024 per EA under NDC 00574029701. Its NADAC has been published 1 times since Jan 10, 2018.

The High Outlier badge above means this manufacturer's average price in the hydromorphone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

HYDROMORPHONE HCL ER 32 MG TAB

hydromorphone hydrochloride
$40.1024per EA
High Outlier
DEA Schedule CII

Strength

32 mg/1

Manufacturer

Padagis US LLC

NDC

00574029701

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

1/10/2018

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204278

On Market Since

5/22/2015

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE HCL ER 32 MG TAB has been published 1 times since Jan 10, 2018, and over the past 5 years it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$40.1024 per EA
All-time high$40.1024 (Jan 10, 2018)
All-time low$40.1024 (Jan 10, 2018)
Median price$40.1024
Average price$40.1024
Weeks tracked1
Tracking sinceJan 10, 2018

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

N/A

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the hydromorphone hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of HYDROMORPHONE HCL ER 32 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 32 MG TAB, manufactured by Padagis US LLC, is $40.1024 per EA (NDC 00574029701), effective Jan 10, 2018.

How has the price of HYDROMORPHONE HCL ER 32 MG TAB changed over time?

Over the past 5 years, the NADAC for HYDROMORPHONE HCL ER 32 MG TAB has held within roughly two percent of its current level. It has been tracked across 1 weekly CMS publications since Jan 10, 2018.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 32 MG TAB?

Since Jan 10, 2018, the NADAC for HYDROMORPHONE HCL ER 32 MG TAB has ranged from a low of $40.1024 (Jan 10, 2018) to a high of $40.1024 (Jan 10, 2018), with a median of $40.1024 per EA.

Are there cheaper alternatives to HYDROMORPHONE HCL ER 32 MG TAB?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYDROMORPHONE HCL ER 32 MG TAB, so no direct lower-cost alternative is listed.

Who manufactures HYDROMORPHONE HCL ER 32 MG TAB?

HYDROMORPHONE HCL ER 32 MG TAB (NDC 00574029701) is labeled by Padagis US LLC, and CMS classifies it as a generic product.